Longitudinal Follow-up of High Viscosity Glassionomer IonoStar Plus Versus a Composite Bulk X-tra-Fil Combined With Futurabond U (Splith Mouth Study): Reunion Island, Circus of Mafate (CVB)
Longitudinal Follow-up of High Viscosity Glassionomer IonoStar Plus Versus a Composite Bulk X-tra-Fil Combined With Futurabond U (Splith Mouth Study)
Sponsor: University Hospital, Montpellier
Terminated
Covid situation / recruitment difficulties
Other terminated trials from University Hospital, Montpellier
Listed as NCT03568253, this NA trial focuses on Caries and remains terminated or withdrawn. Sponsored by University Hospital, Montpellier, it has been updated 5 times since 2018, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
Status: Unknown → Terminated
-
Jul 2024 — Sep 2024 [monthly]
Unknown NA
Status: Unknown Status → Unknown
-
Jul 2022 — Jul 2024 [monthly]
Unknown Status NA
Status: Recruiting → Unknown Status
-
Jan 2021 — Jul 2022 [monthly]
Recruiting NA
-
Jul 2018 — Jan 2021 [monthly]
Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Montpellier
For direct contact, visit the study record on ClinicalTrials.gov .